December 20, 2018
Taisho Pharmaceutical Holdings has offered to acquire Bristol-Myers Squibb’s French consumer healthcare unit, UPSA, for US$1.6 billion, with the potential closing of the deal expected during the first half of 2019, the two companies said on December 19. This is...read more